In our third speaker interview, we sat down with Xuemei Cai, Head of Clinical Research, Digital Sciences & Translational Imaging at Pfizer. She shared her thoughts on the current landscape of the digital biomarkers space, and gave an update on what Pfizer are doing in the space.
To hear more from Xuemei, join us at the Digital Biomarkers and Digital Measurements Summit where she will be sharing her insights alongside other industry leaders.